Navigation Links
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
Date:9/17/2007

-- Major study of more than 2,100 patients with hip fracture shows significant 35% reduction in subsequent osteoporotic fractures with Reclast

-- Results published in The New England Journal of Medicine show significant 28% reduction in overall mortality seen in study patients

treated with Reclast -- Few patients currently receive osteoporosis treatments following hip

fracture despite high risk of morbidity and mortality (1)

-- Reclast, recently FDA approved for treatment of postmenopausal

osteoporosis, shown effective in reducing spine and hip fractures in

another study

EAST HANOVER, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Results of the first ever clinical study in osteoporosis patients who have had a hip fracture show that a once-yearly infusion of Reclast(R) (zoledronic acid) Injection reduced the risk of subsequent fractures by 35% compared to placebo.

This study found that the risk of death was significantly reduced by 28% in the Reclast group compared to the placebo group (101 versus 141 deaths, respectively). Osteoporosis patients with hip fractures may face devastating consequences, with almost a quarter of people over age 50 who suffer a hip fracture dying within one year (2). Among those who survive, 50% require assistance walking, 25% require long-term nursing care and all remain at high risk for fracture (3). Yet, few men and women with hip fractures are diagnosed and treated for osteoporosis following a hip fracture (1).

The landmark study, which included more than 2,100 men and women, was published online today as an early release article in The New England Journal of Medicine and presented simultaneously at the annual meeting of the American Society for Bone & Mineral Research (ASBMR).

"Experts agree that the serious consequences of osteoporosis can be prevented, yet the condition is often under-diagnosed and under-tre
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CLEVELAND , May 22, 2013 /PRNewswire/ ... Software,s enterprise content management (ECM) ... Meditech,s Hospital Information System .  These organizations ... IT system and will use OnBase to ... corporate initiatives.   (Logo:  ...
(Date:5/22/2013)... STEPh, Inc., a full service medical communications ... web site ( http://www.stephreports.com ) dedicated to ... STEPh Reports STEPh Reports are comprehensive critical ... STEPh Report assesses the competitive landscape by individual drug ... and specific key issues.  STEPh Reports are written by ...
(Date:5/22/2013)... , May 22, 2013   Life Line ... screening services announced today the creation of a unique ... . MCM is a population health ... MCM,s growing list of clients. These important expanded services ... chronic conditions earlier. Effective prevention reduces cost of care ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... for prostate cancer treatment medications from Dendreon and ... with advanced prostate cancer were prolonged almost four ... The drug, which could reach the market in 2011, is ... to change clinical practice by providing a new treatment option ...
... ( www.pneumrx.com ), a medical device company dedicated to ... disease, today announced that it has received CE Mark ... System to treat the later stages of emphysema.   ... invasive device intended to improve lung function in emphysema ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System 2
(Date:5/22/2013)... Nearly 50,000 veterans appeals were received by the ... with even more—54,033—expected by fiscal year-end 2013. However, veterans ... the agency reports reduced decisions and a reduced workforce, ... services. The BVA is an agency of the ... received 49,611 cases in FY 2012, it reached decisions ...
(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- People ... likely to attempt suicide, whether or not they also ... a new study. "Clinicians who are seeing patients ... at increased risk of suicide," said study co-author Mark ... Resource and Evaluation Center in Ann Arbor, Mich. ...
(Date:5/22/2013)... Bodybuilding.com is giving back to ... 2013) Bodybuilding.com will be donating $1 from EVERY purchase made ... “We are extremely grateful for the men and women who ... DeLuca, CEO and founder of Bodybuilding.com. “It’s an honor to ... much. Hire Heroes USA is an amazing organization that supports ...
(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Migraines and depression ... new research indicates the combination of the two may ... brain. , , Already aware that people with migraines ... determine if having both conditions together affected total brain ... -- isn,t alarming, study authors said, but needs further ...
Breaking Medicine News(10 mins):Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3
... Providers ,Stuck with the Check, for Expensive $10,Billion ... of its campaign,to highlight the costs associated with ... Association (PCMA) has unveiled,a new print advertisement that ... The Check?", The ad highlights how "prompt ...
... the blood sugar disease may help the heart, researchers ... researchers say they,ve identified a new pathway that increases ... diabetes. , A team at the University of California, ... may reduce this inflammation and possibly reduce the risk ...
... 2007 The preterm birth rate rose again in 2005 ... the urgent need for a sustained, comprehensive plan to address ... the terrible consequences of an early birth, the more determined ... birth and how it can be prevented, said Dr. Jennifer ...
... medicine procedures that detect and evaluate heart disease, ... treat overactive thyroids and some cancersare performed each ... do provide patients with adequate information about nuclear ... study supported by the Centers of Disease Control ...
... EAGAN, Minn., Dec. 6 The Blue ... $1,151,700 in grants -- $810,000,under Growing Up Healthy: ... with New Americans, and $135,000 in related,grants., ... the healthy,growth and development of children under age ...
... the expert,level of healthcare in Germany contribute significantly ... This results in positive,returns for investors. During the ... the River Centre in St. Paul, Minnesota, Germany,s,inward ... the,advantages of Germany as an investment location., ...
Cached Medicine News:Health News:Diabetes Linked to Blood Vessel Inflammation 2Health News:Patients need to know that nuclear medicine procedures can trigger radiation alarms 2Health News:Patients need to know that nuclear medicine procedures can trigger radiation alarms 3Health News:Patients need to know that nuclear medicine procedures can trigger radiation alarms 4Health News:Blue Cross Foundation Invests in Community Health 2Health News:Blue Cross Foundation Invests in Community Health 3Health News:Blue Cross Foundation Invests in Community Health 4Health News:LifeScience Alley 2007: German Healthcare Market Offers Gateway to Europe 2
Micro-retractor arm 12"....
... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: